Logo

American Heart Association

  118
  0


Final ID:

Panel Discussion

  • Wiviott, Stephen  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Stephen Wiviott: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Consultant:ICON:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Researcher:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
DANGER-SHOCK (primary Results at TCT)

Moller Jacob, Thiele Holger

TRISCEND II 1-Year Outcomes (primary results at TCT)

Hahn Rebecca, Thourani Vinod, Kodali Susheel

More abstracts from these authors:
SGLT2 inhibitors: the new antiarrhythmic around the block?

Patel Siddharth, Wiviott Stephen

Polygenic Risk Score Associated With Kidney Disease Progression In Patients With Cardiometabolic Risk Factors

Park Jun, Marston Nicholas, Kamanu Frederick, Melloni Giorgio, Lai Yi-pin, Giugliano Robert, Scirica Benjamin, Wiviott Stephen, Sabatine Marc, Ruff Christian

You have to be authorized to contact abstract author. Please, Login
Not Available